Posted in

Mechanisms of Negative-Strand RNA Synthesis Mediated by Positive-Sense RNA Genomes

Mechanisms of Negative-Strand RNA Synthesis Mediated by Positive-Sense RNA GenomesI. Molecular Framework of Replication Initiation

Positive-sense RNA (+ssRNA) genomes serve dual roles upon host cell entry:

  1. Immediate Translation Template: Direct synthesis of viral replicase complexes (RdRp, helicases, cofactors)
  2. Replication Blueprint: Formation of membrane-bound replication organelles (ROs) where negative-strand RNA synthesis occurs
    Mechanisms of Negative-Strand RNA Synthesis Mediated by Positive-Sense RNA Genomes

(Fig. 1: Replication Organelle Assembly)
Description: Endoplasmic reticulum membranes (yellow) invaginating to form double-membrane vesicles (DMVs). Viral +ssRNA (blue) recruits host proteins (purple) and RdRp (red) to initiate replication.


II. Stepwise Mechanism of Negative-Strand Synthesis

Step 1: Replicase Complex Assembly

  • Structural Requirements:
    • cis-acting RNA elements: Conserved stem-loops in 5’/3′ UTRs (e.g., coronavirus TRS-L) serve as RdRp loading platforms
    • Host factors: hnRNPs stabilize RNA structures for replicase binding
      Mechanisms of Negative-Strand RNA Synthesis Mediated by Positive-Sense RNA Genomes

Step 2: Template Activation

  • Genome Uncoating: Viral helicases unwind secondary structures in +ssRNA
  • Replication Fork Formation: RdRp binds template at precise initiation sites (e.g., PepMV hp2 stem-loop)

Step 3: Negative-Strand Elongation

  • Processive Polymerization: RdRp synthesizes complementary RNA in 5’→3′ direction
    Mechanisms of Negative-Strand RNA Synthesis Mediated by Positive-Sense RNA Genomes
  • Template Switching: Discontinuous transcription at TRS-B sites generates subgenomic RNAs
    Mechanisms of Negative-Strand RNA Synthesis Mediated by Positive-Sense RNA Genomes

(Fig. 2: Negative-Strand Synthesis Pathway)
Description: RdRp (red) bound to +ssRNA template (blue) synthesizing complementary negative-strand RNA (green). Insets show conserved stem-loop structures directing initiation.


III. Key Molecular Players

Component Function Viral Example
RdRp Complex Catalytic RNA synthesis Coronavirus nsp12-nsp7-nsp8
cis-Acting Elements Replication initiation sites PepMV hp1/hp2 stem-loops
Template-Switching Signals Subgenomic RNA synthesis Coronavirus TRS-B motifs
Host Factors Stabilize replication complexes hnRNPs, DDX helicases

IV. Structural Dynamics of Replication Intermediates

A. Replication Complex Architecture

  • Membrane Scaffolding: ROs concentrate replicase components while shielding dsRNA from immune sensors
  • Asymmetric Replication: (-)RNA templates produce 10-100x more (+)RNA progeny

B. RNA Secondary Structures

  • Pseudoknots: Maintain RdRp processivity during elongation (e.g., flavivirus 3’SL2)
  • Slippery Sequences: Facilitate template switching at TRS sites

(Fig. 3: RNA Replication Intermediate)
Description: Molecular view of dsRNA replication complex. Negative-strand (green) base-paired with +ssRNA template (blue). RdRp (red) with nascent RNA chain (yellow).


V. Regulation of Negative-Strand Synthesis

Temporal Control Mechanisms

  1. Proteolytic Activation: Viral proteases cleave replicase precursors into functional complexes
  2. Phosphorylation Switches: Host kinases regulate RdRp activity
  3. RNA Modifications: N6-methyladenosine modulates template accessibility

Strand-Specific Fidelity

  • Error Rate: ~10⁻⁴ mutations/base due to lack of proofreading
  • Evolutionary Advantage: Facilitates rapid host adaptation and immune evasion

VI. Therapeutic Targeting Opportunities

Inhibition Strategies

Target Inhibitor Class Mechanism
RdRp Active Site Nucleotide analogs (Remdesivir) Chain termination
Template Recognition Aptamers Block cis-element binding
RO Formation Cyclophilin inhibitors (Cyclosporine) Disrupt membrane scaffolding

Diagnostic Applications

  • Replication Markers: dsRNA-specific antibodies detect active infection
  • Antiviral Screening: Reporter-based replicon systems
    Mechanisms of Negative-Strand RNA Synthesis Mediated by Positive-Sense RNA Genomes

VII. Synthetic Biology Applications

Engineered Replicon Systems

  • VEEV-Based Platforms: Self-replicating RNAs for sustained protein expression
  • mRNA Vaccine Production: Alphavirus replicons amplifying antigen expression 50x

(Fig. 4: Synthetic Replicon Workflow)
Description: Engineered +ssRNA (blue) with replicase genes (red) and GOI (purple). Continuous amplification via (-)RNA intermediates (green) in transfected cells.


VIII. Unresolved Mechanistic Questions

  1. How do RdRp complexes maintain processivity across >20kb genomes?
  2. What triggers the switch from translation to replication?
  3. Why are (-)RNA synthesis rates strictly limited compared to (+)RNA production?

“Positive-strand RNA viruses exemplify genomic economy: a single molecule serves as infectious agent, mRNA template, and replication blueprint—rewriting central dogma constraints.”
— Cell, 2024


Data sourced from publicly available references. For collaboration inquiries, contact: chuanchuan810@gmail.com.

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注